(Q34187712)

31 July 2017

title

Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment (English)

1 reference

mild cognitive impairment

31 July 2017

0 references

cognitive dysfunction

1 reference

based on heuristic

inferred from title

1 reference

13

0 references

Alzheimer's Disease Neuroimaging Initiative

19

object named as

Alzheimer's Disease Neuroimaging Initiative

1 reference

31 July 2017

Kewei Chen

2

0 references

Michael W. Weiner

15

object named as

Michael W Weiner

1 reference

31 July 2017

18

Eric M Reiman

1 reference

31 July 2017

17

William J Jagust

1 reference

31 July 2017

6

Adam Fleisher

1 reference

31 July 2017

14

Danielle J Harvey

1 reference

31 July 2017

16

Robert A Koeppe

1 reference

31 July 2017

Napatkamon Ayutyanont

4

object named as

Napatkamon Ayutyanont

1 reference

31 July 2017

5

Jessica B S Langbaum

1 reference

31 July 2017

7

Cole Reschke

1 reference

31 July 2017

10

Gene E Alexander

1 reference

31 July 2017

Xia Wu

1

1 reference

31 July 2017

Li Yao

3

1 reference

31 July 2017

Wendy Lee

8

1 reference

31 July 2017

Xiaofen Liu

9

1 reference

31 July 2017

Dan Bandy

11

1 reference

31 July 2017

Norman L Foster

12

1 reference

31 July 2017

publication date

1 August 2010

1 reference

Journal of Neuroscience Methods

31 July 2017

published in

1 reference

31 July 2017

volume

192

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

277-285

1 reference

Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952503

Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952503

Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952503

Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952503

Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952503

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952503

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952503

18Fluorodeoxyglucose positron emission tomography studies in presumed Alzheimer cases, including 13 serial scans.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952503

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952503

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952503

Current concepts in mild cognitive impairment

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952503

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952503

FDG PET imaging in patients with pathologically verified dementia.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952503

Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952503

Alzheimer's disease: focal cortical changes shown by positron emission tomography.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952503

10.1016/J.JNEUMETH.2010.07.030

28 October 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference